Newsletter Archive

  1. 02.08.16 -- 4 Takeaways From Cell & Gene Therapy World
    2/8/2016

    02/08/16 BioProcess Online Newsletter

  2. 02.03.16 -- Should AbbVie’s IPR Triumph Worry The Biosimilar Industry?
    2/3/2016

    02/03/16 BioProcess Online Newsletter

  3. 02.01.16 -- 5 Questions About Biosimilars For 2016
    2/1/2016

    02/01/16 BioProcess Online Newsletter

  4. 01.27.16 -- Risks That Threaten A Multi-Product Pipeline
    1/27/2016

    01/27/16 BioProcess Online Newsletter

  5. 01.25.16 -- What Biosimilars Can Learn From The Generics Market
    1/25/2016

    01/25/16 BioProcess Online Newsletter

  6. 01.21.16 -- Combination Product Insights Special Edition
    1/21/2016

    1/21/2016 Combination Product Insights Special Edition

  7. 01.20.16 -- 2016: What Biosimilar Makers Need To Know
    1/20/2016

    01/20/16 BioProcess Online Newsletter

  8. 01.18.16 -- Study: Regulatory Concerns Slow Innovation
    1/18/2016

    01/18/16 BioProcess Online Newsletter

  9. 01.13.16 -- 2016: Top Trends In Biopharma
    1/13/2016

    01/13/16 BioProcess Online Newsletter

  10. 01.11.16 -- The Case For More Rare Disease Research Funding
    1/11/2016

    01/11/16 BioProcess Online Newsletter